ABSTRACT
In the period of January of 1985 to January of 1995, 6 cases of massive hypertrophy of the mammary gland were diagnosed from 60,000 patients seen in the External Consultation of the Service of Gynecological Oncology. The age oscillated between 11 and 27 years old, with an average of 20.8 years. One case was unilateral and the 5 remaining, bilateral; 3 coexisted with pregnancy. The treatment consisted of reductive mammoplasty. This pathology is a rare entity, with not very well defined etiology in which apparently there are involved hormonals receptors and an unusual sensibility to hormones although they are at normal serum levels.
Subject(s)
Breast/pathology , Mammaplasty/methods , Adolescent , Adult , Breast/surgery , Child , Estrogens/blood , Estrogens/physiology , Female , Humans , Hypertrophy/surgery , PregnancyABSTRACT
The carcinoma of the Fallopian tube is at the present time, one of the most rare gynecologic tumors, representing approximately less than 1% in world literature, being in our experience of 0.15%. We presented two cases of adenocarcinoma of the Fallopian tube, seen in a lapse of 25 years, not diagnosed preoperatorily with the clinical trial of abnormal bleeding, negative biopsy of endometrium and adnexal mass. As it is written in the literature, the diagnosis is rarely established previous to the operation and it usually corresponded to an adenocarcinoma. The classification of the FIGO for the stage is used. In relation to the survival follow-up: the stages I and II present 60% approximately of survival to the five years and it is suggested radiotherapy additional to the surgery; however, according to some authors this doesn't improve the survival.
